| Cash and cash equivalents |
677.18M |
| Restricted cash and cash equivalents |
384.56M |
| Securities available-for-sale, $752,091 and $728,558 pledged as collateral as of June 30, 2011 and December 31, 2010, respectively |
| Corporate loans, net of allowance for loan losses of $188,874 and $209,030 as of June 30, 2011 and December 31, 2010, respectively |
| Corporate loans held for sale |
| Residential mortgage-backed securities, at estimated fair value |
| Equity investments, at estimated fair value, $15,694 and $12,036 pledged as collateral as of June 30, 2011 and December 31, 2010, respectively |
213.1M |
| Derivative assets |
32.9M |
| Interest and principal receivable |
16.67M |
| Other assets |
11.23M |
| Total assets |
6.33B |
| Liabilities |
| Collateralized loan obligation secured debt |
| Credit facilities |
| Convertible senior notes |
| Junior subordinated notes |
249.73M |
| Accounts payable, accrued expenses and other liabilities |
| Accrued interest payable |
18.72M |
| Related party payable |
3.53M |
| Derivative liabilities |
52.32M |
| Total liabilities |
4.65B |
| Preferred shares, no par value, 50,000,000 shares authorized and none issued and outstanding at June 30, 2011 and December 31, 2010 |
0 |
| Common shares, no par value, 500,000,000 shares authorized, and 178,127,870 and 177,848,565 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively |
0 |
| Paid-in-capital |
2.76B |
| Accumulated other comprehensive income |
| Accumulated deficit |
-1.15B |
| Total shareholders' equity |
1.68B |
| Total liabilities and shareholders' equity |
6.33B |
| Liabilities |
| Collateralized loan obligation secured debt |
| Accrued interest payable |
